TNF and rheumatoid arthritis: A prior study compared retention rates following TNFα inhibitor treatment (etanercept, infliximab, and adalimumab) in rheumatoid arthritis, psoriatic arthritis and AS, and found the cumulative survival to favor AS patients.25